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Abstract
Background: Multimorbidity (MM) is one of the major challenges health systems currently face. Management of
time length of a medical consultation with a patient with MM is a matter of concern for doctors.
Methods: A systematic review was performed to describe the impact of MM on the average time of a medical
consultation considering the Preferred Reporting Items for Systematic Review and Meta-analyses (PRISMA)
guidelines. The systematic online searches of the Embase and PubMed databases were undertaken, from January
2000 to August 2018. The studies were independently screened by two reviewers to decide which ones met the
inclusion criteria. (Kappa = 0.84 and Kappa = 0.82). Differing opinions were solved by a third person. This systematic
review included people with MM criteria as participants (two or more chronic conditions in the same individual).
The type of outcome included was explicitly defined – the length of medical appointments with patients with MM.
Any strategies aiming to analyse the impact of MM on the average consultation time were considered. The length
of time of medical appointment for patients without MM was the comparator criteria. Experimental and
observational studies were included.
Results: Of 85 articles identified, only 1 observational study was included, showing a clear trend for patients with
MM to have longer consultations than patients without MM criteria (p < 0.001).
Conclusions: More studies are required to better assess allocation length-time for patients with MM and to
measure other characteristics like doctors’ workload.
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Background
Multimorbidity (MM) is defined by the European Gen-
eral Practice Research Network as “any combination of
chronic disease with at least one other disease (acute or
chronic) or biopsychosocial factor (associated or not) or
somatic risk factor” [1]. This is sometimes simplified to,
“the simultaneous occurrence of two or more chronic
diseases in the same individual” [2]. MM is now one of
the main challenges faced by health systems at an inter-
national level and occupies a considerable part of the
daily activity of General Practitioners/Family Doctors
(GPs/FMs) around the world [3–6].
With an ever-ageing world population, MM and its
consequences, are becoming a major issue in public
health and primary care. According to United Nations
data [7, 8], Europe has the largest percentage of popula-
tion aged 60 or over (25%) [7]. In 2015 the number of
people in the world aged 60 years and older was 901 mil-
lion [8]. It is projected that in 2030 this figure will rise
to 1.4 billion (a 56% increase since 2015) and stand at
2.1 billion in 2050 [8]. Several studies have shown that
there is a significant association between age [2] and the
prevalence of MM, most national health systems not
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being prepared or able to cope with this rapid ageing
with many demands [5, 6]. MM reduces life expectancy
and quality of life (QoL) [5]. However, QoL can increase
if the quality of care (QoC) improves [9], and this can
require additional consultation time.
So, it is imperative to think about the most correct
approach to patients with MM in order to maximize the
QoC provided by the Health Services (HS), and so
ensure a better quality of life.
GPs/FMs medical team face various difficulties in
caring for a patient with MM like lack of resources; con-
sultation time restrictions [10]; lack of interdisciplinary
care/teams; inadequate patient support (largely relying
on community-based support services); inadequate tools
(guidelines are drawn up strictly for specific diseases and
not for the MM patient); the attitude of the patient
(often discouraged and poorly engaged) [4, 11].
Information about the length-time of a consultation
with a patient with MM is essential to better organize
and deliver healthcare. To our knowledge, no previous
review has summarized data related to: What is the im-
pact of having MM on the medical consultation?; and Is
the average length-time consultation with a patient with
MM longer than for a patient without MM?.
Methods
A systematic review was performed considering the Pre-
ferred Reporting Items for Systematic Review and Meta-
Analyses (PRISMA) guidelines for systematic reviews
and meta-analysis, not following any review protocol.
This research proposal has been submitted to and
approved by the Faculty of Medicine at the University of
Coimbra.
Eligibility criteria
The PICO model has been followed to define the ques-
tion and allow the most effective literature search. The
population (P) was defined as people with MM. The
most widely used definition of MM was used, which is
the coexistence of two or more chronic conditions in
the same individual [2]. The World Health Organization
(WHO) definition of chronic disease was adopted,
namely, health problems that require ongoing care over
a long period of time (years or decades) [12].
As interventions (I) any strategies aiming to analyse
the impact of MM on the average consultation time
were considered. The length of time of medical appoint-
ment for patients without MM was the comparator cri-
terion (C). As outcome (O), it was expected to explicitly
define the length-time of medical appointments with pa-
tients with MM. Experimental and observational studies
were included. Studies which did not specify the time
spent on medical appointments were excluded.
Information sources and search strategy
The systematic online searches were implemented using
combinations of keywords in the following electronic
databases: the Embase and PubMed databases, from
January 1, 2000 until August 31, 2018, an 18-year time
period, to find pertinent studies. The authors believe
that the most reliable way to assess consultation time is
through computerized clinical records, which were very
scarce before 2000.
The search within the Embase database used the fol-
lowing combination of keywords: (‘multiple chronic con-
ditions’/exp. OR’multiple chronic conditions’) AND
(‘consultation time’ OR ((‘consultation’/exp. OR consult-
ation) AND (‘time’/exp. OR time))); (‘multiple chronic
conditions’/exp. OR ‘multiple chronic conditions’) AND
(‘primary health care’/exp. OR ‘primary health care’)
AND (‘time’/exp. OR time); ‘consultation’/exp. AND
‘multiple chronic conditions’/exp./mj; ‘multiple chronic
conditions’/exp. AND (‘time’/exp. OR’average’/exp. OR
‘consultation’/exp). For the PubMed database the combi-
nations of keywords were: “Chronic Disease/epidemiolo-
gy”[Mesh] AND ((“referral and consultation”[MeSH
Terms] OR (“referral”[All Fields] AND “consultatio-
n”[All Fields]) OR “referral and consultation”[All Fields]
OR “consultation”[All Fields]) AND (“time”[MeSH
Terms] OR “time”[All Fields])).
The search was limited to papers in English, Portu-
guese, Spanish and French published in internationally-
recognized peer-reviewed journals to ensure the reliabil-
ity of the data. No other limits were imposed during this
stage of the study. References in the identified literature
were scanned for further literature when it was found
appropriate to support work decisions.
Data extraction and quality assessment
The potentially relevant studies containing quantitative
consultation time data were selected in two stages. First,
the titles and abstracts quoted in the literature search
were independently screened by two reviewers (the first
and third co-authors of this work) to decide which ones
to accept, meeting the inclusion criteria (Kappa = 0.84).
Those not meeting the inclusion criteria were excluded.
Differing opinions on a study’s inclusion were resolved
by a third person (the second co-author of this work).
Secondly, the researchers independently read and ana-
lysed the integrity of the matching studies and tried to
reach an agreement concerning eligibility (Kappa = 0.82).
Those not meeting the inclusion criteria were excluded.
Differing opinions on a study’s inclusion were resolved
by a third person (the second co-author of this work).
The quality and risk of bias of the included studies was
assessed using the Newcastle-Ottawa Scale (NOS), more
precisely, the Newcastle-Ottawa scale adapted for cross-
sectional studies [13]. The NOS is widely used and
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recommended by the Cochrane Collaboration [14], and
the authors found it suitable for the purpose of this
work. This tool assesses three aspects of a study: the
selection of the sample; the comparability of the groups;
and the outcome (assessment of outcome and statistical
test). It is composed of 7 items and classifies the study
in 4 possible levels: Very good (9–10 points), Good (7–8
points), Satisfactory (5–6 points) and Unsatisfactory (0–
4 points). Any disagreement was resolved through
consensus.
This systematic review was conducted using Covi-
dence 13, the standard production platform used for
Cochrane reviews, which was used for the data and
records management.
Outcomes and statistical analysis
The patients were split into two groups, those with and
those without MM, and the relative frequencies were




As described in Fig. 1, the electronic database searches
started with 85 potentially eligible references (16 in
PubMed and 59 in Embase). Of these, 5 were duplicates
and were thus excluded and 31 were considered
irrelevant based on a review of the title and abstract.
The remaining studies were fully read, analysed and
assessed for eligibility; 36 were then excluded due to
unsatisfactory outcome [3, 16–49], 5 due to unsuitable
study design [50–54], 4 due to unsuitable patient popu-
lation [11, 55–57], 2 due to inadequate language [58, 59]
and 1 to unsatisfactory setting [60]. In the end, 1 study
was included [61].
Study characteristics and quality
The main relevant features and outputs of the study
were extracted for the purpose of this systematic review
and are summarized in Table 1.
The included study was conducted between 2008 and
2009 in Denmark, over 12 months. It involved 404 gen-
eral practitioners (GPs) participants and a total of 8236
contacts. It included patients aged 40 years or more,
grouped as those without any chronic condition and
those with one, two, three or more chronic conditions.
During the study period, the GPs completed a one-
page registration form for each of their patient contacts.
Of the various items that were registered, the ones rele-
vant for this review were information on chronic
diseases and length-time of consultation. Quality assess-
ment result, performed as described in methodology, is
presented in Table 2. The quality of the study was
considered satisfactory (score 6 out of a maximum score
Fig. 1 PRISMA Flow Diagram [15]– Literature search and selection process for studies included
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of 10), its main weakness being in the comparability
section.
Results of study
Table 3 shows the relationship between the length of
consultation time and the type of patient (with and with-
out MM). There is a clear significant trend for patients
with MM to have longer consultations than patients
without MM (p < 0.001).
More than 25% of MM patients had a consultation
length-time of at least 16 min while more than 75% of
the patients without MM had a consultation length-time
under 15 min. Length-time consultation on both types of
patients is more frequently between 6 and 15 min. There
is a significant difference, however, in the percentage of




The present systematic review sought to find out if the
average consultation time spent on patients with MM is
longer than that spent on patients who do not meet the
MM criteria. It could only identify one study [61],
undertaken in Denmark, in which the consultation time
was logged as a function of the number of chronic dis-
eases. This study revealed a tendency for consultations
to take longer for patients with MM than for those with-
out MM. However, the study was not directly aimed at
answering this question and it did not take confounding
factors into account. In addition, it does not describe the
calculation to determine the sample size of the study
and it could be inaccurate to study this specific outcome
still it answers the posed question.
Comparison with existing literature
The small number of publications in the literature on
this subject shows that more studies should be designed
to investigate the impact of MM on the consultation
length-time. It is vital to analyse this issue in order to
manage resources so that they meet the actual need, and
to ensure the services provided by health services, na-
tional or private, are appropriate. It will thus be possible
to guarantee better quality health services and outcomes
for these patients. In fact, MM is about a patient with
more than two chronic diseases or one chronic disease
with biopsychosocial factor (associated or not) or som-
atic risk factor, so illness being included and not only
about the specific sufferances [1, 11].
In studies with calculated size population represen-
tative random samples it is important that accurate
methods are used to measure the real length-time of
a consultation using appropriate tools. Confounding
factors must be eliminated as the time spent on
administrative work. Only direct observation using
video recording has been proven to obtain accurate
values when measuring the duration of consultations
[62], which could be a procedure that mitigates many
of the errors previously mentioned. It is essential to
identify beforehand any possible confounding factors
inherent to the patients (for example, hearing diffi-
culty, education level, age, socio-economic level), in-
herent to the doctor (in particular, a change in
behaviour due to the participation in the research
study – Hawthorne effect [63]), and inherent to the
consultation/institution (for example, glitches in com-
puter systems, organization of necessary information
in the health informatics records, coding errors, tele-
phone call interruptions). The time lost searching for
information in consultation, the friendliness of clinical
informatics and the time spent on records are also is-
sues to be studied and thought of [64, 65]. Health de-
terminants are factors to be studied in such a MM
population for better health and social outcomes [66].
The data analysis must be evaluated using objective
validated laboratory methods and, if possible, it should
be a blind assessment. Statistical tests used to analyse
the data must be appropriate and clearly described.
Measures of association, including confidence intervals
and the P value, must be presented.
Table 3 Length of consultation time and type of patient (with
and without MM criteria)





< 5 min 293 11.7 96 7.7 p < 0.001
6–15min 1686 67.3 804 64.9
16–30 min 485 19.4 314 25.3
> 30 min 42 1.7 25 2.0
Total 2506 100 1239 100
Table 2 Quality of study - Newcastle-Ottawa Scale adapted for cross-sectional studies












Comparability of subjects in
different outcome groups on







* - (b) * ** - (c) * * 6 Satisfactory
* - score of 1 point; ** - score of 2 points; (b) – Calculation not reported; (c) – Data/results not adjusted for all relevant confounders not provided
Cross-sectional Studies: Very Good Studies (9–10 points); Good Studies (7–8 points); Satisfactory Studies (5–6 points); Unsatisfactory Studies (0 to 4 points)
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Further considerations
The QoL of MM patients can increase if the quality of
QoC improves, so the improvement of the quality of
services provided by the HS is an important matter.
Patients with MM require more medical resources and
longer consultation length. Medical teams need to be
interdisciplinary and guidelines drawn up for specific
diseases need to be improved for MM patients.
HS need to provide good patient support and to
acquire knowledge to deal with often discouraged and
poorly engaged patients.
The appropriate length for a consultation of a patient
with MM needs to be taken into account to better organize
and deliver healthcare, taking into account that the
frequency of consulting and the number of problems to dis-
cuss are significantly higher in the patients with MM [67].
Strengths and limitations
The main limitation of this systematic review was the
difficulty in ensuring that all the relevant literature was
included. Even though the research used two of the main
databases – PubMed and Embase – there could be other
relevant material in grey literature, not taken into
account in the present work to ensure the reliability of
the data.
The scarcity of the literature that was found was a
limitation for this review. The one publication found,
besides not directly answering our question, also does
not take confounding factors into account, and does not
describe the calculation to determine the sample size of
the study. However, it does highlight the relevance of
the subject matter. The authors believe that the lack of
recognition of MM and fragile patients in the clinical
management of patients is also one of the reasons why
scientific research has paid less attention to MM.
Conclusions
This impact of MM on the duration of a consultation
has hardly been studied, this systematic review shows.
A tendency for consultations of patients with MM to
take longer than those without MM was found in the
only one study with “satisfactory” quality which met the
inclusion criteria.
So more research is needed to acquire more informa-
tion on this subject, important to deal not only with
diseases but with the person suffering from MM for
consultation must have the adequate length duration to
enable doctors and stake-holders with a proper quantifi-
cation of the time and associated costs.
If a longer consultation time is confirmed, it will be
important to rethink and adapt GPs’ lists of patients in
order to achieve better medical care providing agendas
with specific times and allocating enough time for all the
required tasks.
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